Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Acta Parasitol ; 58(4): 519-26, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24338313

ABSTRACT

Sexually transmitted diseases are a major cause of acute disease worldwide, and trichomoniasis is the most common and curable disease, generating more than 170 million cases annually worldwide. Trichomonas vaginalis is the causal agent of trichomoniasis and has the ability to destroy in vitro cell monolayers of the vaginal mucosa, where the phospholipases A2 (PLA2) have been reported as potential virulence factors. These enzymes have been partially characterized from the subcellular fraction S30 of pathogenic T. vaginalis strains. The main objective of this study was to purify a phospholipase A2 from T. vaginalis, make a partial characterization, obtain a partial amino acid sequence, and determine its enzymatic participation as hemolytic factor causing lysis of erythrocytes. Trichomonas S30, RF30 and UFF30 sub-fractions from GT-15 strain have the capacity to hydrolyze [2-(14)C-PA]-PC at pH 6.0. Proteins from the UFF30 sub-fraction were separated by affinity chromatography into two eluted fractions with detectable PLA A2 activity. The EDTA-eluted fraction was analyzed by HPLC using on-line HPLC-tandem mass spectrometry and two protein peaks were observed at 8.2 and 13 kDa. Peptide sequences were identified from the proteins present in the eluted EDTA UFF30 fraction; bioinformatic analysis using Protein Link Global Server charged with T. vaginalis protein database suggests that eluted peptides correspond a putative ubiquitin protein in the 8.2 kDa fraction and a phospholipase preserved in the 13 kDa fraction. The EDTA-eluted fraction hydrolyzed [2-(14)C-PA]-PC lyses erythrocytes from Sprague-Dawley in a time and dose-dependent manner. The acidic hemolytic activity decreased by 84% with the addition of 100 µM of Rosenthal's inhibitor.


Subject(s)
Phospholipases A2/isolation & purification , Phospholipases A2/metabolism , Trichomonas vaginalis/enzymology , Amino Acid Sequence , Animals , Chromatography, Affinity , Chromatography, High Pressure Liquid , Erythrocytes/drug effects , Hemolysis , Hydrogen-Ion Concentration , Molecular Weight , Phospholipases A2/chemistry , Phospholipases A2/genetics , Rats , Rats, Sprague-Dawley , Tandem Mass Spectrometry , Trichomonas vaginalis/genetics
2.
Exp Parasitol ; 125(4): 394-9, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20350542

ABSTRACT

Sphingomyelinase (SMase) activity was measured in Entamoeba histolytica particulate and soluble subcellular fractions. The effects on SMase of incubation time, total protein concentration, pH, and several divalent cations were determined. SMase-C and other unidentified esterase activity were detected in soluble and particulate fractions. SMase-C was 94.5-96.0% higher than the unidentified esterase activity. Soluble and insoluble SMase-C specific activities increased with protein dose and incubation time. Soluble and insoluble SMase-C activities were maximum at pH 7.5 and were dependent on Mg(2+), Mn(2+), or Co(2+), and inhibited by Zn(2+), Hg(2+), Ca(2+), and EDTA. SMase-C was active in the pH range of 3-10 and its maximum activity was at pH 7.5. The soluble and insoluble SMases have remarkably similar physicochemical properties, strongly suggesting that E. histolytica has just one isoform of neutral SMase-C that had not been described before and might be essential for E. histolytica metabolism or virulence.


Subject(s)
Entamoeba histolytica/enzymology , Esterases/metabolism , Sphingomyelin Phosphodiesterase/metabolism , Animals , Calcium/pharmacology , Cobalt/pharmacology , Cricetinae , Dose-Response Relationship, Drug , Entamoeba histolytica/pathogenicity , Hydrogen-Ion Concentration , Magnesium/pharmacology , Male , Manganese/pharmacology , Mercury/pharmacology , Mesocricetus , Protozoan Proteins/metabolism , Sphingomyelin Phosphodiesterase/drug effects , Time Factors , Virulence , Zinc/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL